Vibrant

About:

Vibrant develops an AI drug development platform to focus on building immune system-related drug pipelines.

Top Investors: Matrix Partners China, HongShan, Redhill Capital

Description:

Vibrant develops an AI drug development platform to focus on building immune system-related drug pipelines. The company will use artificial intelligence algorithms to accelerate the efficiency of drug development in various aspects such as target discovery, drug design, and drug efficacy evaluation; at the same time, the company expects to continuously improve the success rate of drug development through sustainable data accumulation and algorithm optimization. It was founded and headed by Dr. Wang Luquan and is based in Guangzhou, Guangdong, China.